Home >
Community >
Why is the contraceptive Saheli not sold in the United States?
Upvote
14
Downvote
+ Pharma
+ Pharmaceuticals
Posted by
Malcolm Sargeant
Why is the contraceptive Saheli not sold in the United States?
Ormeloxifene (Saheli) is only marketed in India, nowhere else in the world.
It’s said that under ideal circumstances its failure rate is just 1–2%, (the usual oral hormonal contraceptive pill under ideal circumstances a lot lower 0.3%!, although under real life circumstances it can be as high as 8 - 12%).
It might be that the investments needed to do the required registration studies aren’t considered worthwhile by the producers, them already having a large domestic market in India, and women in other parts of the world not being familiar with taking one tablet a week (the first 12 weeks twice a week a tablet) so that might hinder the uptake.
Ormeloxifene (Saheli) is only marketed in India, nowhere else in the world.
It’s said that under ideal circumstances its failure rate is just 1–2%, (the usual oral hormonal contraceptive pill under ideal circumstances a lot lower 0.3%!, although under real life circumstances it can be as high as 8 - 12%).
It might be that the investments needed to do the required registration studies aren’t considered worthwhile by the producers, them already having a large domestic market in India, and women in other parts of the world not being familiar with taking one tablet a week (the first 12 weeks twice a week a tablet) so that might hinder the uptake.
Ormeloxifene (Saheli) is only marketed in India, nowhere else in the world.
It’s said that under ideal circumstances its failure rate is just 1–2%, (the usual oral hormonal contraceptive pill under ideal circumstances a lot lower 0.3%!, although under real life circumstances it can be as high as 8 - 12%).
It might be that the investments needed to do the required registration studies aren’t considered worthwhile by the producers, them already having a large domestic market in India, and women in other parts of the world not being familiar with taking one tablet a week (the first 12 weeks twice a week a tablet) so that might hinder the uptake.
Ormeloxifene (Saheli) is only marketed in India, nowhere else in the world.
It’s said that under ideal circumstances its failure rate is just 1–2%, (the usual oral hormonal contraceptive pill under ideal circumstances a lot lower 0.3%!, although under real life circumstances it can be as high as 8 - 12%).
It might be that the investments needed to do the required registration studies aren’t considered worthwhile by the producers, them already having a large domestic market in India, and women in other parts of the world not being familiar with taking one tablet a week (the first 12 weeks twice a week a tablet) so that might hinder the uptake.
More
VOTE
Saheli' is well accepted because it contains a non-steroidal preparation and has very few side effects.
Saheli' is well accepted because it contains a non-steroidal preparation and has very few side effects.
More
VOTE